This inventor holds 1 USPTO granted patent. Top assignee: Gendel Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations in Ultrasound Therapy by Anna Maria Rollan Haro
Introduction
Anna Maria Rollan Haro is an accomplished inventor based in Coleraine, Ireland. She has made significant contributions to the field of medical technology, particularly in ultrasound therapy. Her innovative approach focuses on enhancing the selectivity of ultrasound treatments, which can lead to improved patient outcomes.
Latest Patents
Anna Maria Rollan Haro holds a patent for her invention titled "Ultrasound therapy for selective cell ablation." This groundbreaking method involves sensitizing target cells to ultrasound energy using an electric field stimulus. The process, known as "electrosensitisation," allows for the disruption of target cells, such as tumor cells, without harming non-target cells. This invention not only increases the effectiveness of ultrasound therapy but also minimizes damage to surrounding healthy tissues. Additionally, the patent includes an apparatus for implementing the method and assays for identifying gene products involved in apoptosis.
Career Highlights
Throughout her career, Anna has demonstrated a commitment to advancing medical technology. Her work has the potential to revolutionize how diseases are treated, particularly in oncology. By focusing on the selectivity of treatments, she aims to provide safer and more effective options for patients.
Collaborations
Anna Maria Rollan Haro collaborates with Anthony Patrick McHale, contributing to the development and refinement of her innovative techniques. Their partnership exemplifies the importance of teamwork in the field of research and invention.
Conclusion
Anna Maria Rollan Haro's contributions to ultrasound therapy represent a significant advancement in medical technology. Her innovative methods have the potential to improve treatment outcomes for patients while minimizing harm to healthy cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile